Prospective Cohort With Hemopathy in Languedoc-Roussillon
ConditionHematologic Malignancy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Montpellier
About this trial
Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.
Eligibility criteria
Qualifiers
Age over 18
Consultant or hospitalized patient for suspected malignant hemopathy and justifying further exploration or patient with a diagnosis of malignant hemopathy less than 6 months old at the time of signing the consent
Having signed an informed consent
Affiliated with a social security scheme
Disqualifiers
Minor or major protected
Patients who have received treatment for hematological pathology
Trial design
Treatments tested in this trial
- hematologic malignancy
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov